• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾脏疾病中的血管损伤:高血压之外的因素

Vascular damage in kidney disease: beyond hypertension.

作者信息

Stinghen Andréa E M, Pecoits-Filho Roberto

机构信息

Basic Pathology Department, Laboratory of Experimental Nephrology, Universidade Federal do Paraná, 80531-980 Curitiba, PR, Brazil.

出版信息

Int J Hypertens. 2011;2011:232683. doi: 10.4061/2011/232683. Epub 2011 Aug 14.

DOI:10.4061/2011/232683
PMID:21876786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3160729/
Abstract

Chronic kidney disease (CKD) is highly prevalent and a multiplier of cardiovascular disease (CVD) and cannot be completely explained by traditional Framinghan risk factors. Consequently, greater emphasis has been placed in nontraditional risk factors, such as inflammation, endothelial dysfunction, sympathetic overactivation, protein-energy wasting oxidative stress, vascular calcification, and volume overload. The accumulation of uremic toxins (and the involvement of genetic factors) is responsible for many of the clinical consequences of a condition known as uremia. In this brief paper, we discuss mechanisms involved in the vascular damage of CKD patients, aiming to point out that important factors beyond hypertension are largely responsible for endothelial activation and increased CVD risk, with potential impact on risk stratification and development of novel therapeutic options.

摘要

慢性肾脏病(CKD)非常普遍,是心血管疾病(CVD)的倍增因素,无法完全用传统的弗明汉姆风险因素来解释。因此,人们更加关注非传统风险因素,如炎症、内皮功能障碍、交感神经过度激活、蛋白质-能量消耗、氧化应激、血管钙化和容量超负荷。尿毒症毒素的蓄积(以及遗传因素的参与)是导致尿毒症这种疾病许多临床后果的原因。在这篇简短的论文中,我们讨论了CKD患者血管损伤的相关机制,旨在指出高血压以外的重要因素在很大程度上导致了内皮激活和CVD风险增加,这可能对风险分层和新治疗方案的开发产生影响。

相似文献

1
Vascular damage in kidney disease: beyond hypertension.肾脏疾病中的血管损伤:高血压之外的因素
Int J Hypertens. 2011;2011:232683. doi: 10.4061/2011/232683. Epub 2011 Aug 14.
2
Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.尿毒症毒素、氧化应激、慢性肾脏病中的动脉粥样硬化及肾移植。
Oxid Med Cell Longev. 2021 Feb 11;2021:6651367. doi: 10.1155/2021/6651367. eCollection 2021.
3
Role of Uremic Toxins in Early Vascular Ageing and Calcification.尿毒症毒素在早期血管老化和钙化中的作用。
Toxins (Basel). 2021 Jan 3;13(1):26. doi: 10.3390/toxins13010026.
4
Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.肠道微生物群衍生的尿毒症毒素对心血管系统矿化的贡献。
Toxins (Basel). 2021 Apr 10;13(4):274. doi: 10.3390/toxins13040274.
5
[Chronic kidney disease-a cardiovascular high-risk constellation].[慢性肾脏病——心血管高危综合征]
Internist (Berl). 2020 Apr;61(4):340-348. doi: 10.1007/s00108-019-00686-y.
6
[Chronic renal disease, inflammation and atherosclerosis: new concepts about an old problem].[慢性肾病、炎症与动脉粥样硬化:关于一个老问题的新观念]
Rev Assoc Med Bras (1992). 2007 Sep-Oct;53(5):446-50. doi: 10.1590/s0104-42302007000500022.
7
Heart and kidney disease: a cardiovascular high-risk constellation.心脏和肾脏疾病:心血管高危综合征。
Herz. 2021 Jun;46(3):206-211. doi: 10.1007/s00059-020-05012-z. Epub 2020 Dec 30.
8
Arterial stiffness: A brief review.动脉僵硬度:简要综述。
Tzu Chi Med J. 2020 Sep 16;33(2):115-121. doi: 10.4103/tcmj.tcmj_44_20. eCollection 2021 Apr-Jun.
9
Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.心肾综合征背景下的血管病变:蛋白结合尿毒症毒素的作用
Am J Physiol Heart Circ Physiol. 2017 Jul 1;313(1):H1-H13. doi: 10.1152/ajpheart.00787.2016. Epub 2017 Apr 14.
10
Cellular senescence determines endothelial cell damage induced by uremia.细胞衰老决定了尿毒症引起的内皮细胞损伤。
Exp Gerontol. 2013 Aug;48(8):766-73. doi: 10.1016/j.exger.2013.04.004. Epub 2013 Apr 25.

引用本文的文献

1
Peripheral artery disease In West Africans with diabetes: a risk factor profile analysis.西非糖尿病患者的外周动脉疾病:危险因素剖析
Int J Cardiol Cardiovasc Risk Prev. 2025 Jul 11;26:200469. doi: 10.1016/j.ijcrp.2025.200469. eCollection 2025 Sep.
2
Research progress on the kidney-gut-brain axis in brain dysfunction in maintenance hemodialysis patients.维持性血液透析患者脑功能障碍中肾-肠-脑轴的研究进展
Front Med (Lausanne). 2025 Mar 6;12:1538048. doi: 10.3389/fmed.2025.1538048. eCollection 2025.
3
Preoperative predictive indicators for resolution of hypertension in patients with unilateral primary aldosteronism: development of a nomogram model.单侧原发性醛固酮增多症患者高血压缓解的术前预测指标:列线图模型的建立
Langenbecks Arch Surg. 2025 Jan 28;410(1):52. doi: 10.1007/s00423-025-03615-w.
4
Cognitive Impairment in Chronic Kidney Disease Is Associated with Glymphatic System Dysfunction.慢性肾脏病中的认知障碍与类淋巴系统功能障碍有关。
Kidney Dis (Basel). 2023 Jun 14;9(5):384-397. doi: 10.1159/000530635. eCollection 2023 Oct.
5
Predictors of successful outcome after adrenalectomy for unilateral primary aldosteronism.单侧原发性醛固酮增多症肾上腺切除术成功的预测因素。
Front Endocrinol (Lausanne). 2023 Aug 11;14:1205988. doi: 10.3389/fendo.2023.1205988. eCollection 2023.
6
[Evaluation of Cerebral Blood Flow Using Arterial Spin Labeling in Patients with Chronic Kidney Disease].[慢性肾脏病患者动脉自旋标记法评估脑血流量]
Taehan Yongsang Uihakhoe Chi. 2020 Jul;81(4):912-919. doi: 10.3348/jksr.2020.81.4.912. Epub 2020 Jul 30.
7
Predictive factors of clinical success after adrenalectomy in primary aldosteronism: A systematic review and meta-analysis.原发性醛固酮增多症肾上腺切除术临床成功的预测因素:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2022 Aug 18;13:925591. doi: 10.3389/fendo.2022.925591. eCollection 2022.
8
Glymphatic system dysfunction in patients with early chronic kidney disease.早期慢性肾脏病患者的淋巴系统功能障碍
Front Neurol. 2022 Aug 8;13:976089. doi: 10.3389/fneur.2022.976089. eCollection 2022.
9
Phosphate restriction using a processed clay mineral reduces vascular pathologies and microalbuminuria in rats with chronic renal failure.使用加工过的粘土矿物限制磷酸盐可减少慢性肾衰竭大鼠的血管病变和微量白蛋白尿。
BMC Nephrol. 2022 Apr 28;23(1):162. doi: 10.1186/s12882-022-02743-5.
10
Disentangling the Relationship Between Chronic Kidney Disease and Cognitive Disorders.理清慢性肾病与认知障碍之间的关系。
Front Neurol. 2022 Feb 25;13:830064. doi: 10.3389/fneur.2022.830064. eCollection 2022.

本文引用的文献

1
Does uremia cause vascular dysfunction?尿毒症会导致血管功能障碍吗?
Kidney Blood Press Res. 2011;34(4):284-90. doi: 10.1159/000327131. Epub 2011 Jun 21.
2
Does it matter how parathyroid hormone levels are suppressed in secondary hyperparathyroidism?在继发性甲状旁腺功能亢进症中,甲状旁腺激素水平如何被抑制重要吗?
Semin Dial. 2011 May-Jun;24(3):298-306. doi: 10.1111/j.1525-139X.2011.00935.x.
3
A gut feeling on endotoxemia: causes and consequences in chronic kidney disease.内毒素血症的直觉:慢性肾脏病的病因和后果。
Nephron Clin Pract. 2011;118(2):c165-72; discussion c172. doi: 10.1159/000321438. Epub 2010 Dec 16.
4
SDF-1α as a therapeutic stem cell homing factor in myocardial infarction.基质细胞衍生因子-1α 作为心肌梗死后治疗性的干细胞归巢因子。
Pharmacol Ther. 2011 Jan;129(1):97-108. doi: 10.1016/j.pharmthera.2010.09.011. Epub 2010 Oct 20.
5
Sevelamer carbonate reduces inflammation and endotoxemia in an animal model of uremia.碳酸司维拉姆可降低尿毒症动物模型中的炎症和内毒素血症。
Blood Purif. 2010;30(3):153-8. doi: 10.1159/000319850. Epub 2010 Sep 21.
6
Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease.慢性肾脏病:公共卫生重点,也是心血管疾病早发的先兆。
J Intern Med. 2010 Nov;268(5):456-67. doi: 10.1111/j.1365-2796.2010.02269.x.
7
Genome-wide association studies in nephrology research.肾病学研究中的全基因组关联研究。
Am J Kidney Dis. 2010 Oct;56(4):743-58. doi: 10.1053/j.ajkd.2010.05.018. Epub 2010 Aug 21.
8
Mechanism of endothelial dysfunction in chronic kidney disease.慢性肾脏病中内皮功能障碍的机制。
Clin Chim Acta. 2010 Oct 9;411(19-20):1412-20. doi: 10.1016/j.cca.2010.06.019. Epub 2010 Jun 22.
9
Therapeutic strategies for heart failure in cardiorenal syndromes.心肾综合征心力衰竭的治疗策略。
Am J Kidney Dis. 2010 Oct;56(4):759-73. doi: 10.1053/j.ajkd.2010.04.012. Epub 2010 Jun 16.
10
The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease.CXCL12(SDF-1alpha)在健康和疾病期间调节免疫中的多重作用。
J Leukoc Biol. 2010 Sep;88(3):463-73. doi: 10.1189/jlb.0909602. Epub 2010 May 25.